Europe could beat U.S. in biopharma innovation

11/13/2009 | Wall Street Journal, The

Europe could overthrow the U.S. as a leader in the biotech-drug industry if U.S. lawmakers decide to shorten market exclusivity for brand-name biopharmaceuticals under health reform legislation, writes Benedetto Della Vedova, former member of the European Parliament. A proposal to provide five to seven years of protection would stifle innovation and diminish the chance of U.S. companies to be globally competitive, giving way for European firms to create the next generation of biologic drugs, Della Vedova writes.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations